Prophylactic Antibiotic Use in Reconstruction of Nasal Mohs Defects
Otolaryngology–Head and Neck Surgery · 2024
DOI: 10.1002/ohn.842 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2024. Verfasst von Jaclyn Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Mohs Surgery, Antibiotic Prophylaxis. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To evaluate the effect of prophylactic antibiotics on outcomes and complications following surgical reconstructions of nasal Mohs defects in the outpatient setting. Study Design Retrospective cohort study.
Setting
Single tertiary care center, July 2021 to June 2023.
Methods
All adult patients who underwent reconstruction of nasal Mohs defects in an outpatient office setting were examined. Patient demographics, surgical details, prophylactic postprocedural antibiotic use, and postprocedural complications (infection, flap or graft necrosis, wound dehiscence) were collected. Outcomes and complications were compared between patients who received and did not receive prophylactic antibiotics using χ 2 , Kruskal‐Wallis, and multivariable logistic regression.
Results
A total of 211 patients met inclusion criteria. A majority of reconstructions utilized a local flap (70%), followed by a skin or composite graft (22%), then an interpolated flap (8%). Over half of patients (55%) were prescribed prophylactic antibiotics. Postprocedural complications were documented in 16 patients (7.6%), including infection (3.3%) and flap or graft loss or necrosis (1.4%). The rate of complications did not differ based on receipt of antibiotics. The only factors independently associated with the development of complications were history of chemoradiation and reconstruction with skin or composite grafts.
Conclusion
Prophylactic antibiotics after nasal Mohs reconstructions performed in the office setting were not associated with any differences in the rate of postprocedural complications, including surgical site infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- School of Medicine, Texas A&M University College of Medicine, Bryan, Texas, USA.
- Division of Facial Plastic and Reconstructive Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Zitieren
APA
Lee, J., Longino, E. S., Desisto, N. G., Sharma, R. K., Stephan, S. J., Yang, S. F., & Patel, P. N. (2024). Prophylactic Antibiotic Use in Reconstruction of Nasal Mohs Defects. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.842
Vancouver
Lee J, Longino ES, Desisto NG, Sharma RK, Stephan SJ, Yang SF, et al. Prophylactic Antibiotic Use in Reconstruction of Nasal Mohs Defects. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.842
BibTeX
@article{Lee2024,
author = {Lee, Jaclyn and Longino, Elizabeth S and Desisto, Nicole G and Sharma, Rahul K and Stephan, Scott J and Yang, Shiayin F and Patel, Priyesh N},
title = {Prophylactic Antibiotic Use in Reconstruction of Nasal Mohs Defects},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
doi = {10.1002/ohn.842}
}
EUVIMED